FDA cites low weight loss and safety questions with Arena Pharmaceutical's experimental drug
WASHINGTON - Federal health officials say weight loss with a new diet drug from Arena Pharmaceuticals was minimal and safety questions remain about its effects on the heart.
No comments:
Post a Comment